Related by context. All words. (Click for frequent words.) 71 clinicopathological 69 APOE genotype 68 genetic loci 66 clinicopathologic 66 etiologic 65 endophenotypes 65 genomewide 65 Multiple logistic regression 65 neuroanatomical 65 neuropathologic 65 epistasis 64 prognostic indicators 64 etiological 64 pathophysiological mechanisms 64 DNA methylation patterns 64 familial clustering 64 clinico pathological 64 #q# deletion 64 explanatory variables 64 alexithymia 63 Logistic regression 63 differential gene expression 63 pharmacodynamic markers 63 susceptibility loci 63 EGFR mutation status 63 bivariate 63 unmeasured confounding 63 aetiological 63 interobserver 63 IntroductionThe 63 p#/CBP 62 prostate carcinogenesis 62 gene loci 62 ABCB1 62 nongenetic 62 linkage disequilibrium LD 62 pharmacogenetic testing 62 metabolomic profiles 62 mechanistic studies 62 clinicopathological features 62 biologic pathways 62 neurocognition 62 psychosocial variables 62 studies GWAS 62 affective psychosis 62 metaanalysis 62 biologic plausibility 62 genotypic 62 orthologous genes 62 sociodemographic characteristics 62 genomic variation 61 intracellular signal transduction 61 Genetic predisposition 61 COMT genotype 61 phylogenetic analyzes 61 familial aggregation 61 gene polymorphisms 61 Univariate 61 multiple logistic regression 61 generalisability 61 generalized estimating 61 TMPRSS2 ERG fusion 61 logistic regression analyzes 61 Meta analyzes 61 quantitative trait loci 61 intestinal permeability 61 microarray gene expression 61 genomic biomarker 61 phenotypic expression 61 genetic polymorphisms 61 electrophysiologic 61 epigenomic 61 mitochondrial DNA mtDNA 61 neurofibrillary 61 visceral adiposity 61 protein conformation 61 nosology 61 prostate cancer CaP 61 colorectal carcinogenesis 61 prospective multicentre 61 multivariate analyzes 61 gene rearrangements 60 CaPSURE 60 meta analytic 60 functional annotation 60 HLA DRB1 60 validate biomarkers 60 Leydig cell 60 haplotype map 60 chronicity 60 TXNIP 60 genetic variants associated 60 extramedullary 60 sociodemographic variables 60 microstructural 60 phenotypic differences 60 ConclusionThis 60 generalized vitiligo 60 genomewide association studies 60 plasma lipid 60 breast cancer subtypes 60 neuroactive 60 nucleosome positioning 60 metabolomic profiling 60 allelic 60 Poisson regression 60 neurobiological basis 60 syndromic 60 oncogenesis 60 pathophysiologic 60 immunoregulatory 60 Lymph node 60 GABRA2 60 neuropathological 60 vascular endothelial 60 multigene 60 molecular determinants 60 KRAS mutation status 60 causal inference 60 univariate 60 splice variants 60 observable traits 60 PITX2 60 RRM1 60 chemosensitivity 60 comorbid disorders 60 molecular biomarker 60 clefting 60 laterality 60 genetic locus 60 convergent validity 60 genome rearrangements 59 BPS IC 59 microRNA profiling 59 psychobiological 59 prognostic markers 59 ADRB2 59 tumor histology 59 pathogenic mechanisms 59 premorbid 59 pathophysiological 59 mutated K ras 59 drug metabolizing enzymes 59 lipoprotein metabolism 59 prognostic significance 59 Arabidopsis genes 59 multivariate Cox 59 autosomal dominant inheritance 59 monogenic 59 Univariate analysis 59 genomic alterations 59 intraobserver 59 Treg cell 59 EBV infection 59 microRNA expression 59 miRNA expression 59 variant rs# 59 cardiometabolic syndrome 59 LRP5 59 NOD mouse 59 oncologic outcomes 59 unmeasured confounders 59 underlying molecular mechanisms 59 physiologic mechanisms 59 pharmacodynamic parameters 59 causal variants 59 transcriptional regulation 59 histone methylation 59 motor neuron degeneration 59 Multivariate logistic regression 59 correlational 59 transcriptomics 59 phenotypic traits 59 PCA3 gene 59 underlying pathophysiology 59 functional gastrointestinal disorders 59 genetic relatedness 59 causative genes 59 subclinical atherosclerosis 59 chromosomal regions 59 Multivariate analysis 59 Gene Ontology 59 genomewide association study 59 metabolomic 59 pharmacodynamic PD 59 HNPCC 59 histological subtype 59 Mathematical modeling 59 neuropsychiatric diseases 59 eTag assays 59 inferential statistics 59 statistical correlations 59 HER2 expression 59 SNP rs# [002] 59 genomic profiling 59 genomic transcriptomic 59 antiapoptotic 59 FGFs 59 PITX2 methylation 59 Mantel Haenszel 59 biopsychosocial 59 ADME properties 59 pathogenetic mechanisms 59 functional neuroimaging 59 serum PTH 59 NPM1 gene 59 proteomic analysis 59 Helicobacter pylori infection 59 Prognostic factors 59 CEACAM1 59 serum biomarkers 59 airway hyperresponsiveness 59 neuroligins 59 morphometrics 59 MTHFD1L gene 59 SNP rs# [001] 59 neurocognitive function 59 sociodemographics 58 urothelial cancer 58 meta regression 58 multivariate logistic regression 58 Socio demographic 58 SLC#A# [002] 58 immunohistochemical 58 serologic 58 Genetic variants 58 promoter hypermethylation 58 pleiotropic effects 58 toxicogenomic 58 phenotyping 58 biobehavioral 58 Genotypic 58 neurosensory 58 DNA demethylation 58 neuropsychological impairments 58 chromatin immunoprecipitation ChIP 58 dysbindin gene 58 causative mutations 58 Heritability 58 GPC5 58 hormone receptor status 58 pharmacokinetic pharmacodynamic 58 PON1 gene 58 protein ligand 58 hematopoietic cancers 58 VKORC1 58 somatic mutation 58 cis regulatory 58 CD# expression [002] 58 methylation patterns 58 dose proportionality 58 Multiple linear regression 58 prognostically 58 prognostic biomarkers 58 immunological mechanisms 58 DNA methyltransferases 58 atherothrombotic 58 obstructive coronary artery 58 Chlamydia trachomatis infection 58 covariate 58 chi squared 58 conditional logistic regression 58 neurexins 58 psychophysiological 58 seropositivity 58 molecular mechanisms underlying 58 heterologous expression 58 prognostic variables 58 pathogenetic 58 Cognitive behavioral 58 COX2 58 CSF biomarkers 58 microbiomes 58 KRAS variant 58 nutrient supplementation 58 thrombophilia 58 perfusion CT 58 SSc 58 #S rRNA gene 58 neurotrophic 58 TCF#L# gene 58 histone modifications 58 bone metabolism 58 Multivariable logistic regression 58 cognitive affective 58 Genetic variation 58 epistatic 58 endothelial activation 58 neural substrates 58 multivariate statistical 58 multivariable analysis 58 interactome 58 STAT4 58 kidney urologic 58 microsatellite instability 58 CYP#D# genotype 58 ADAMTS# 58 enterotypes 58 proton MR spectroscopy 58 genotypic resistance 58 sirtuin activators 58 bronchopulmonary dysplasia BPD 58 orthologous 58 Mechanistic studies 58 Phenotypic 58 microarray experiments 58 GBA mutations 58 histopathological 58 enzyme catalysis 58 2D 4D length 58 epitope mapping 58 physicochemical 58 intestinal microbiota 58 comparative genomic 58 pathophysiological effects 58 phenotypic 58 TMPRSS2 ERG 58 cAMP signaling 58 genetic determinants 58 tumorigenicity 58 BRAF V#E 58 E. histolytica 58 histocompatibility 58 effector function 58 logistic regression models 58 multivariable logistic regression 58 #q# deletion syndrome 58 electroencephalographic 58 subclinical disease 58 previously uncharacterized 58 zebra finch genome 58 TRAF1 C5 58 microarray datasets 57 circulating endothelial cells 57 histologic subtype 57 MYH9 57 morphologic 57 FFR measurements 57 HIV tropism 57 Observational studies 57 tumoral 57 missense mutations 57 BRAF V#E mutation 57 Linear regression 57 multiple linear regression 57 enzymatic pathways 57 assortative mating 57 TLE3 57 neuronal signaling 57 socioeconomic variables 57 γ secretase 57 biomolecular interactions 57 moderately heritable 57 murine models 57 immunoregulation 57 transgene expression 57 protein coding RNAs 57 logistic regressions 57 heritable traits 57 ultrastructural 57 telomerase activation 57 transcriptomes 57 heritable disorders 57 epigenetic markers 57 lesional 57 osteocalcin protein 57 BCL#A 57 paternally inherited 57 metastatic lymph nodes 57 coexpression 57 radiographic findings 57 multigenic 57 molecular phylogenetic 57 antioxidant supplementation 57 K ras mutations 57 intracranial stenosis 57 neuropsychological assessment 57 de novo mutations 57 multifactorial disease 57 folate metabolism 57 transgenic mouse models 57 Cognitive impairment 57 predictive validity 57 antibody mediated 57 somatic mutations 57 transcriptional profiling 57 sCJD 57 PDZ domains 57 neuropsychological impairment 57 cellular microenvironment 57 epigenetic modification 57 orofacial 57 biochemical abnormalities 57 serum lipid 57 ZNF# 57 redox active 57 Membrane proteins 57 toxicologic 57 differentially expressed genes 57 euthymic patients 57 histone acetyltransferase 57 H#K#me# 57 oncogenic transformation 57 sporadic Creutzfeldt Jakob 57 aggregated Abeta 57 radiochemotherapy 57 colorectal adenoma 57 primate genomes 57 serologic tests 57 eIF4E 57 methodologic 57 methodological rigor 57 biomarker identification 57 morphological traits 57 logistic regression analysis 57 genetic polymorphism 57 thyroid carcinoma 57 plexiform 57 impaired insulin secretion 57 quasispecies 57 glial tumors 57 Angiotensin converting enzyme 57 thermodynamic stability 57 putative biomarkers 57 Fc receptor 57 dysbindin 57 DQB1 * 57 protein tyrosine phosphatase 57 p# activation 57 mechanistic insights 57 Haplotype 57 LPA gene 57 pathogenic mutations 57 perilipin 57 BioMAP ® 57 protein isoforms 57 S. maltophilia 57 neuroimaging studies 57 tumor subtypes 57 mucosal immune 57 presymptomatic 57 longitudinal cohort 57 multivariate regression analysis 57 PARP inhibition 57 norepinephrine reuptake inhibition 57 fusion enhancers 57 TRAIL induced apoptosis 57 sociodemographic 57 haematopoietic 57 PDE# inhibitors 57 introgression 57 retrospectively analyzed 57 protein ligand interactions 57 atherothrombosis 57 HERmark assay 57 uncharacterized genes 57 intercellular signaling 57 therapeutically relevant 57 genomic biomarkers 57 metaplasia 57 left ventricular diastolic 57 maternally inherited 57 chromosome #p#.# 57 germline mutations 57 modifier genes 57 Bonferroni correction 57 haematological 57 p# biomarker 57 PRESEPT study 56 HER2 overexpression 56 CHI#L# 56 A3 adenosine receptor 56 miRNA profiling 56 transcriptomic 56 primary hyperparathyroidism 56 CDH1 56 Zevalin consolidation 56 KRAS mutation 56 guideline concordant 56 pathophysiologic mechanisms 56 susceptibility locus 56 flow cytometric 56 endogenous hormones 56 silico prediction 56 Socioeconomic status 56 plasma adiponectin 56 Regression analysis 56 IgG1 antibodies 56 immunotherapeutic approaches 56 PON1 activity 56 serum leptin 56 prognostic biomarker 56 scintigraphic 56 cytologic 56 coevolution 56 Heterogeneity 56 NNRTI resistance 56 Molnar Szakacs 56 Kaplan Meier curve 56 substrate specificity 56 Prostatitis 56 intestinal mucosal 56 GSOs 56 anthropometric measurements 56 risk reducing salpingo 56 interpretability 56 TLR antagonists 56 Pearson correlation coefficients 56 pancreatic ductal 56 mutational analysis 56 beta1 integrin 56 predictive biomarkers 56 sporadic ALS 56 nonparametric 56 physico chemical 56 ABCB1 gene 56 metabonomics 56 #q#.# deletion syndrome 56 genetic aberrations 56 reproducible measurements 56 elevated serum ALT 56 multivariable analyzes 56 semistructured interviews 56 serum selenium 56 hierarchical clustering 56 immune modulating 56 IMPROVE HF 56 receptor subtypes 56 ventilation perfusion 56 CINQUIL 56 extrapulmonary 56 aetiology 56 enzyme kinetics 56 KIBRA 56 stereochemical 56 Cardiorespiratory fitness 56 urate oxidase 56 epigenetic changes 56 sequence homology 56 gene expression assays 56 proteomic analyzes 56 comorbid anxiety 56 phenotypic variation 56 glycolytic 56 multivariate regression 56 #S rRNA 56 immunological responses 56 autism susceptibility genes 56 Logistic regression analysis 56 indels 56 cerebrospinal fluid biomarkers 56 chemo immunotherapy 56 Gag polymorphisms 56 MEF2A 56 APOE ε4 56 PTPN# 56 aerodigestive tract 56 intergenic 56 carotid IMT 56 gene locus 56 Accurately identifying 56 P cadherin 56 serum markers 56 allelic variation 56 epigenetic inheritance 56 airway responsiveness 56 causal pathways 56 EndoTAGTM 1 56 HER2 positivity 56 nitrotyrosine 56 dosimetric 56 MYH9 gene 56 chromosome aberrations 56 cytological 56 Descriptive statistics 56 heparanase 56 gastric cardia 56 cardiac repolarization 56 NFTs 56 phylogenetic analysis 56 retrospective cohort 56 monozygotic twins 56 cerebral microbleeds 56 epigenetic regulation 56 non pharmacological interventions 56 multimodality imaging 56 GABAB receptors 56 pharmacogenetic 56 PIK3CA 56 AVPR1A 56 prostate cancer metastasis 56 positional cloning 56 progesterone receptor PR 56 histologic findings 56 Sociodemographic 56 Vaxfectin R 56 5 hydroxymethylcytosine 56 tumor subtype 56 tissue oxygenation 56 genomic imprinting 56 KIF6 carriers 56 APOL1 56 mGluR5 antagonist 56 fetal microchimerism 56 fungal genomes 56 HMGCR 56 STK# gene 56 childhood acute lymphoblastic 56 bioinformatic approaches 56 interobserver reliability 56 Cyclin E 56 genetic ancestry 56 Rigorous scientific 56 non coding RNA 56 Single Nucleotide Polymorphisms SNPs 56 physico chemical properties 56 artifactual 56 periodontal infections 56 subcellular localization 56 fluoroquinolone resistance 56 evolvability 56 ERK signaling 56 previously undescribed 56 NKX#.# 56 gene duplications 56 prostate carcinoma 56 comorbid depression 56 cell signaling pathways 56 genetic biomarkers 56 FUS protein 56 neuro physiological 56 Cancer Genetic Markers 56 neuritic 56 Lp PLA 2 56 adipokines 56 abnormal cytology 56 Tr DNA 56 carcinoids 56 β amyloid 56 causative mutation 56 potency selectivity 56 kinase inhibition 56 chromosomal rearrangement 56 heritable variation 56 visit www.ctia.org 56 immunofluorescent 56 trans palmitoleate 56 M. pneumoniae 56 homologies 56 atherosclerosis regression 56 molecular biomarkers 56 Sjögren syndrome 56 carotid plaque 56 microchimerism 56 IL#R 56 tic severity 56 QSAR models 56 lymphoproliferative disorders 56 Selembu shows 56 glaucomatous 56 pressure natriuresis 56 clinically heterogeneous 56 arterial calcification 56 autonomic dysfunction 56 HbF 56 rs# [004] 56 orthologs 56 bisulfite sequencing 56 favorable pharmacokinetic 56 Cystatin C 56 quantitatively assess 56 FKBP# 56 QTLs 56 Cdc7 56 vasopressin receptor 56 paraneoplastic 56 proteoglycan 56 echocardiographic parameters 56 circadian genes 56 fraternal twin pairs 56 frontostriatal 56 intracellular bacteria 56 Subgroup analyzes 56 TMEM#B 56 bioluminescent imaging 56 spontaneous mutations 56 chromatin modification 56 FDG PET imaging 56 coronary calcification 56 CAM modalities 56 chemoprevention trials 56 SNCA 56 rifamycins 56 lymphovascular invasion 56 plasma selenium 56 spontaneous regression 56 ABO blood 56 inbred strains 56 microsatellite markers 56 synteny 56 Dysregulation 55 Histological 55 radiographic outcomes 55 phenotypic characteristics 55 splice junctions 55 amyloid cascade 55 Comorbidity 55 liver metastasis 55 hepatic fibrosis 55 CSHL scientists 55 immunomodulation 55 somatoform disorders 55 adjuvant systemic 55 morphometric 55 epithelial barrier 55 molecular abnormalities 55 gallstone disease 55 innate immune responses 55 IPAH 55 serum GGT 55 MetaBase TM represents 55 neurocognitive impairment 55 phylogeographic 55 nomograms 55 mTOR inhibition 55 perfusion abnormalities 55 gene expression microarray 55 FDG PET scans 55 #T# L1 55 urolithiasis 55 serum lipid levels 55 metabolite concentrations 55 Clusterin 55 computational algorithms 55 familial pancreatic cancer 55 spirometric 55 CYT# potent vascular disrupting 55 mitochondrial metabolism 55 Genetic variations 55 probands 55 vascular dysfunction 55 serum BDNF 55 nonalcoholic steatohepatitis NASH 55 BRACAnalysis ® 55 STEP BD 55 chromosome #p# [002] 55 NPM1 mutation 55 FGFR2 gene 55 functional polymorphism 55 biomarker assays 55 etiological factors 55 #S rDNA 55 chromosomal anomalies 55 alpha7 NNR 55 chlamydial infection 55 MMP# 55 affective disorders 55 CD# expression [001] 55 bioinformatic analysis 55 MLH1 55 socioeconomic status SES 55 poststroke depression 55 dietary carbohydrate 55 neovascular 55 colorectal tumor 55 bladder carcinoma 55 pancreatic adenocarcinoma 55 KIAA# 55 Bcr Abl mutations 55 microdeletion 55 CpG DNA 55 affective psychoses 55 microRNA biomarkers 55 #beta HSD 1 55 GPNMB expression 55 antimicrobial susceptibility 55 IVIVC 55 Jhdm2a 55 Corus CAD 55 FUS1 55 Tasigna prolongs 55 computational geometry 55 histologic subtypes 55 psoriasis Crohn disease 55 epigenetic alterations 55 atherogenesis 55 methylation markers 55 humoral responses 55 pleiotropic 55 amyloid plaque formation 55 erection hardness 55 PALB2 55 cMET 55 nucleotide substitution 55 toxicogenomics 55 ductal adenocarcinoma 55 pathological angiogenesis 55 conserved sequences 55 genomic rearrangement 55 prefrontal cortical 55 mass spectrometric 55 dietary acrylamide 55 Fc gamma receptor 55 linear pharmacokinetics 55 prospective multicenter study 55 experimentally validated 55 HRCT 55 quantitative gene expression 55 testicular germ cell 55 S1P receptor 55 histologies 55 antiplatelet therapies 55 antibody antigen 55 bile acid metabolism 55 Serological 55 body louse genome 55 APOE e4 55 HG PIN 55 genetic susceptibilities 55 C. pneumoniae 55 ApoE gene 55 epigenetic therapies 55 gastric adenocarcinoma 55 familial predisposition 55 diffusion tensor 55 elevated homocysteine 55 Secondary efficacy endpoints 55 Telomere length 55 molecular subtypes 55 histone H4 55 neurocognitive dysfunction 55 sickle cell hemoglobin 55 hippocampal function 55 detect XMRV 55 neurobiological underpinnings 55 #q#.# [002] 55 thyrotropin levels 55 genomic proteomic 55 MGUS 55 pathogen interactions 55 mechanistically 55 genetic modifiers 55 prospective longitudinal 55 serous ovarian cancer 55 carcinoembryonic antigen 55 Oncogenic 55 Longitudinal studies 55 thiopurine 55 rheumatologic 55 univariate analyzes 55 evolutionary divergence 55 histologically proven 55 Transcriptome 55 empirically validated 55 Skeletal muscle 55 clonal expansion 55 transgenic rats 55 hormone secretion 55 Kufs disease 55 Acetyl L carnitine 55 histological subtypes 55 KLF4 55 multiplex assay 55 hematological parameters 55 OnDose TM 55 modifiable lifestyle 55 hyper IgE syndrome 55 environmental toxicants 55 multi factorial disease 55 prospective observational studies 55 penetrance 55 ENPP1 55 chromosomal instability 55 miRs 55 mechanistic insight 55 stratifying patients 55 hereditary nonpolyposis colorectal cancer 55 inflammatory biomarkers 55 synaptogenesis 55 neural progenitor 55 CP CPPS 55 diathesis 55 MDRD 55 response pCR 55 Cytogenetic 55 atherosclerotic vascular disease 55 CNTNAP2 55 ragweed allergic 55 incidentalomas 55 adipogenic 55 blood coagulation disorders 55 epidemiologic studies 55 ChIP chip 55 catechol O methyltransferase 55 chromosome rearrangements 55 hematopoietic malignancies 55 nonpsychotic 55 Mutational 55 etiologic factors 55 mycobacterial 55 CHD7 55 monogenic diabetes 55 internalizing disorders 55 NPM1 55 CpG island 55 metacognitive 55 comparative genomics 55 mtDNA mutations 55 microbiologic 55 GMX# 55 neuronal circuitry 55 pre mRNA splicing 55 galiximab 55 autoinflammatory diseases 55 neoplastic 55 posttranslational modifications 55 pharmacodynamic biomarkers 55 logistic regression model 55 CYP#C# [002] 55 CYP#D# gene 55 epigenetic mechanisms 55 peptide receptor 55 myopathies 55 sociodemographic factors 55 QSG client 55 genomically 55 transgenic mouse model 55 MECP2 gene 55 transfection efficiency 55 KRAS status 55 EEG recordings 55 MMP9 55 myeloproliferative 55 BARD1 55 hypericin 55 UGT#A# 55 chimp genomes 55 lymphangiogenesis 55 humanin 55 antitumour 55 Apolipoprotein E 55 intact parathyroid hormone 55 CC genotype 55 antiangiogenic agents 55 unmeasured factors 55 ligand receptor 55 telomere lengths 55 malignant phenotype 54 nonhuman primate model 54 nucleotide substitutions 54 autopsied brains 54 human leukocyte antigens 54 posttreatment 54 proteomes 54 manually curated 54 beta amyloid peptides 54 apolipoproteins 54 #HT#A receptor 54 noncognitive 54 herpesviruses 54 CYP#A# enzyme 54 bivariate analyzes 54 neoplastic diseases 54 pharmacokinetic characteristics 54 neurophysiologic 54 mechanistic explanation 54 cerebellar vermis 54 biochemical markers 54 genomic variants 54 CpG rich 54 chemical reactivity 54 proinflammatory mediators 54 fibrotic disease 54 Alternative splicing 54 Relapsing remitting MS 54 DNA methylation markers 54 coactivators 54 KRAS oncogene 54 T SPOT.TB 54 BioMAP 54 biostatistical analysis 54 interrater 54 kallikrein 54 chromatin structure 54 APTIMA HPV 54 cardiometabolic risk 54 CGEMS 54 autosomal 54 biospecimen 54 codon usage 54 NHAMCS 54 transcranial Doppler ultrasound 54 K ras mutation 54 gene expression patterns 54 Epstein Barr Virus EBV 54 bivariate analysis 54 molecular profiling 54 phytoestrogen intake 54 preoperative diagnosis